TGF-β is associated with increased migration and malignant transformation of endometrial carcinomas through activation of estrogen-related receptor alpha (ERRα); it is also associated with invasion and epithelial-to-mesenchymal transition (EMT) [64]. Here, ESRRA is linked to endometrial carcinoma.